{"id":1095,"date":"2025-05-28T15:29:09","date_gmt":"2025-05-28T13:29:09","guid":{"rendered":"https:\/\/aplusa.local\/?post_type=expertise&#038;p=1095"},"modified":"2026-02-16T17:59:05","modified_gmt":"2026-02-16T16:59:05","slug":"oncology","status":"publish","type":"expertise","link":"https:\/\/www.aplusaresearch.com\/fr\/expertise\/oncology\/","title":{"rendered":"Tumeurs solides"},"content":{"rendered":"<p>Les tumeurs solides repr\u00e9sentent l&#039;un des domaines les plus complexes et comp\u00e9titifs de l&#039;oncologie, avec un nombre croissant de nouveaux m\u00e9canismes, des progr\u00e8s scientifiques rapides et une pression accrue sur l&#039;acc\u00e8s aux traitements, le s\u00e9quen\u00e7age et la diff\u00e9renciation. Chez {acf_brand_name}, nous clarifions cette complexit\u00e9 en combinant des donn\u00e9es r\u00e9elles de patients, des donn\u00e9es de march\u00e9 et des donn\u00e9es comportementales avanc\u00e9es.<\/p>\n\n\n\n<p>Notre expertise en tumeurs solides couvre les principaux types de cancers et contextes de prise en charge, et accompagne les \u00e9quipes pharma et biotech dans l\u2019\u00e9valuation des opportunit\u00e9s, l\u2019affinage des propositions de valeur, la compr\u00e9hension des d\u00e9cisions th\u00e9rapeutiques et le suivi de l\u2019\u00e9volution des dynamiques de march\u00e9 tout au long du cycle de vie des produits.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Domaines d\u2019expertise cl\u00e9s<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cancer de la femme : sein \/ ovaires \/ endom\u00e8tre<\/li>\n\n\n\n<li>Cancer de l'homme : prostate<\/li>\n\n\n\n<li>M\u00e9lanome<\/li>\n\n\n\n<li>Vessie<\/li>\n\n\n\n<li>R\u00e9nal<\/li>\n\n\n\n<li>M\u00e9soth\u00e9liome<\/li>\n\n\n\n<li>NSCLC (cancer du poumon non \u00e0 petites cellules)<\/li>\n\n\n\n<li>Biosimilaires et th\u00e9rapies de r\u00e9f\u00e9rence<\/li>\n<\/ul>","protected":false},"featured_media":4034,"template":"","meta":{"_acf_changed":true,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"%%sitetitle%% delivers solid tumor research insights to help pharma teams understand treatment landscapes, stakeholder needs, and market dynamics.","_seopress_robots_index":"","_seopress_analysis_target_kw":"","content-type":""},"class_list":["post-1095","expertise","type-expertise","status-publish","has-post-thumbnail"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/expertise\/1095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/expertise"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/expertise"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/4034"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=1095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}